Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depo-Provera for Pain in Women With Sickle Cell Disease
NCT06665997Phase 4Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Jun 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of medroxyprogesterone acetate in sickle cell disease (SCD), sponsored by University of Pennsylvania. Started Jun 2025; status: recruiting.
02
Drugs
medroxyprogesterone acetate
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT06665997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06665997.